Breast cancer and fertility

Current Treatment Options in Oncology

Volumn 13, Issue 2, 2012, Pages 137-145

  Litton, Jennifer K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Assisted reproductive technologies (ART); Breast cancer; Fertility; Oncofertility; Pregnancy; Reproduction; Treatment

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CLOMIFENE; CYCLOPHOSPHAMIDE; ESTROGEN; FLUOROURACIL; HUMAN MENOPAUSAL GONADOTROPIN; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

AMENORRHEA; ARTICLE; ASSISTIVE TECHNOLOGY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CHEMOSENSITIVITY; CONGENITAL MALFORMATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE MUTATION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; INFERTILITY THERAPY; MULTIPLE CYCLE TREATMENT; OOCYTE RETRIEVAL; OVARY CANCER; OVARY FOLLICLE; OVERALL SURVIVAL; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; RETREATMENT; TUMOR SUPPRESSOR GENE; UTERUS CANCER;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ESTROGENS; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILITY PRESERVATION; GENES, BRCA1; GENES, BRCA2; HUMANS; INFERTILITY, FEMALE; OVARIAN NEOPLASMS; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; UTERINE NEOPLASMS;

EID: 84863727774     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-012-0185-5     Document Type: Article

References (51)

1. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26:3324-30.
2. Theriault RL, Litton JK, Mittendorf EA, et al. Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype. Clin Breast Canc. 2011;11:325-31.
3. Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994;12:888-94.
4. Gnerlich JL, Deshpande AD, Jeffe DB, et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208:341-7.
5. Gonzalez-Angulo A, Broglio K, Kau S-W, et al. Women age G 35 years with primary breast carcinoma. Cancer. 2005;103:2466-72.
6. Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29: E18-20.
7. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;365:1687-717.
8. Partridge AH. Fertility preservation: A vital survivorship issue for young women with breast cancer. J Clin Oncol. 2008;26:2612-3.
9. Partridge AH, Gelber S, Peppercorn J, et al. Webbased survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174-83.
10. Mueller B, Simon M, Deapen D, et al. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98:1131-40.
11. Velentgas P, Daling J, Malone K, et al. Pregnancy after breast carcinoma. Cancer. 1999;85:2424-32.
12. Kroman N, Jensen M-B, Melbye M, et al. Should women be advised against pregnancy after breastcancer treatment? Lancet. 1997;350:319-22.
13. Lee SJ, Schover LR, Partridge AH, et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-31.
14. Schedin P. Pregnancy-Associated breast cancer and metastasis. Nat Rev Cancer. 2006;6:281-91.
15. Anderson W, Matsuno R, Sherman M, et al. Estimating age-specific breast cancer risks: A descriptive tool to identify age interactions. Canc Causes Contr. 2007;18:439-47.
16. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-86.
17. Burkman RT, Tang MT, Malone KE, et al. Infertility drugs and the risk of breast cancer: Findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril. 2003;79:844-51.
18. Kallen B, Finnstrom O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod 26:253-8, 2010. Recent update on a large corhort of infertile women and future risk of cancers.
19. Jensen A, Sharif H, Svare EI, et al. Risk of breast cancer after exposure to fertility drugs: Results from a large Danish Cohort study. Canc Epidemiol Biomarkers Prev. 2007;16:1400-7.
20. Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: Results from a large danish population-based cohort study. Am J Epidemiol. 2009;170:1408-14.
21. dos Santos Silva I, Wark PA, McCormack VA, et al. Ovulation-stimulation drugs and cancer risks: A longterm follow-up of a British cohort. Br J Cancer. 2009;100:1824-31.
22. van Leeuwen FE, Klip H, Mooij TM, et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Human Reproduction 26:3456-3465, 2011. Recent study evaluating the risk of cancer in women who used IVF and other fertility drugs.
23. Zreik TG, Mazloom A, Chen Y, et al. Fertility drugs and the risk of breast cancer: A meta-Analysis and review. Breast Cancer Res Treat. 2010;124:13-26.
24. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365-70.
25. Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time course of bleeding after long-Term amenorrhea after breast cancer treatment. Cancer. 2011;116:3102-11.
26. Byrne J, Fears TR, Gail MH, et al. Early menopause in long-Term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788-93.
27. Partridge A, Gelber S, Gelber RD, et al. Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-Term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007;43:1646-53.
28. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 94:638-44, 2010. Recent analysis looking at fertility for breast cancer patients who remain premenopausal after chemotherapy.
29. Peate M, Meiser B, Friedlander M, et al. It's now or never: Fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer: An Australian Fertility Decision Aid Collaborative Group Study. J Clin Oncol. 2011;29:1670-7.
30. Lee S, Ozkavukcu S, Heytens E, et al. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol. 2010;28:4683-6.
31. Gelber S, Coates AS, Goldhirsch A, et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol. 2001;19:1671-5.
32. Verkooijen HM, Lim GH, Czene K, et al. Effect of childbirth after treatment on long-Term survival from breast cancer. British Journal of Surgery 97:1253-1259, 2010. This is a large and recent cohort of women who went on to have future pregnancies.
33. Azim Jr HA, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: A metaanalysis of 14 studies. European Journal of Cancer 47:74-83, 2010. Excellent meta-Analysis of the available data regarding pregnancy after a diagnosis of breast cancer.
34. Valachis A, Tsali L, Pesce L, et al. Safety of pregnancy after primary breast carcinoma in young women: A meta analysis to overcome bias of healthy mother effect studies. Obstet Gynecol Surv. 2011;65:786-93.
35. Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: Population based study. BMJ. 2007;334:194.
36. Braems G, DenysH,DeWever O, et al.Use of tamoxifen before and during pregnancy. The Oncologist, 2011.
37. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Tecnology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241-6.
38. Oktay K, Türkçüoglu I, Rodriguez-Wallberg KA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation? Fertil Steril. 2011;95:804.e7-804.
39. Donnez J, Squifflet J, Jadoul P, et al. Pregnancy and live birth after autotransplantation of frozenthawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril. 2011;95:1787.e1-4.
40. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. J Clin Oncol. 2008;26:2630-5.
41. Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28:240-4.
42. Pal T, Keefe D, Sun P, et al. Fertility in women with BRCA mutations: A case-control study. Fertil Steril. 2009;93:1805-8.
43. Smith KR, Hanson HA, Mineau GP, et al. Effects of BRCA1 and BRCA2 mutations on female fertility. Proc Biol Sci, epub, Oct. 26, 2011.
44. Kotsopoulos J, Librach C, Lubinski J, et al. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: A case-control study. Canc Causes Contr. 2008;19:1111-9.
45. Wang WH, Kaskar K, Gill J, et al. A simplified technique for embryo biopsy for preimplantation genetic diagnosis. Fertil Steril. 2008;90:438-42.
46. Menon U, Harper J, Sharma A, et al. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod. 2007;22:1573-7.
47. Sagi M, Weinberg N, Eilat A, et al. Preimplantation genetic diagnosis for BRCA1/2-A novel clinical experience. Prenat Diagn. 2009;29:508-13.
48. Wang CW, Hui EC. Ethical, legal and social implications of prenatal and preimplantation genetic testing for cancer susceptibility. Reprod Biomed Online. 2009;19 Suppl 2:23-33.
49. Hawkins M. Pregnancy outcome and offspring after childhood cancer. BMJ. 1994;309:1034.
50. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer-A population-based cohort study from Sweden. PLoS Med. 2006;3:e336.
51. Langagergaard A. Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin's Disease: A review. Clin Epidemiol. 2011;3:7-19.